[Myocardial ischemia with stable angina pectoris: clinico-ergometric evaluation after the use of diltiazem].

Purpose: To evaluate the efficacy of diltiazem versus placebo in patients with stable angina.

Methods: Eight-seven angina pectoris patients, mean age of 57 +/- 9, 82 white and 79 male were evaluated in a randomized, double-blind trial of two groups of patients diltiazem and placebo, 3 to 4 tablets a day (diltiazem 180 to 240 mg daily). The patients were evaluated after laboratory tests and clinical-ergometric examinations.